Prices and COAs verified October 2026

WADA 2026 Prohibited List: Which Peptides Are Banned

WADA 2026 Prohibited List explained for peptide users. BPC-157 under S0, TB-500 under growth factors and CJC-1295 under S2. Full breakdown with citations.

WADA 2026 Prohibited List: Which Peptides Are Banned

Athletes subject to anti-doping rules need clear answers about which peptides are banned and under what conditions. The 2026 World Anti-Doping Agency Prohibited List, effective January 1, 2026, covers BPC-157, TB-500, CJC-1295, Ipamorelin and a wide category of other non-approved substances. We reviewed the full list and cross-referenced it with the peptides most commonly discussed in the research market.

The 2026 WADA Prohibited List (Effective January 1, 2026)

How the List Is Organized

WADA organizes prohibited substances into categories. Sections S0 through S5 cover substances banned at all times. Sections S6 through S9 apply only in competition. The 2026 WADA Prohibited List is published annually and becomes binding on January 1. Athletes are responsible for reviewing the list regardless of whether a substance is named explicitly or falls under a catch-all provision.

S0: Non-Approved Substances (Catch-All)

Section S0 prohibits any pharmacological substance not addressed by subsequent sections that has no current approval by any governmental regulatory health authority for human therapeutic use. It does not require the substance to be named. If a compound lacks regulatory approval for human use anywhere in the world, it is prohibited under S0 at all times.

Peptides on the 2026 List

BPC-157 Under S0 (Non-Approved Substances)

BPC-157 is prohibited at all times under S0. No regulatory authority has approved it. No therapeutic use exemption pathway exists because no approved medical use has been established. The USADA athlete guide has specifically cited BPC-157 as falling under S0. Any detectable amount constitutes a violation.

TB-500 Under Growth Factors (S2)

TB-500, a fragment of Thymosin Beta-4, is listed under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics). Thymosin Beta-4 is named explicitly. TB-500 is covered by that named parent compound. Banned at all times.

CJC-1295 Under S2.2.4 (GH Releasing Factors)

CJC-1295 is a GHRH analogue prohibited under S2.2.4, which covers growth hormone releasing factors and their analogues. It is named in the list. Banned at all times, with or without DAC.

Ipamorelin Under GH Secretagogues

Ipamorelin falls under the GH secretagogues subsection within S2. It is listed by name. Testing laboratories can detect Ipamorelin and its metabolites in urine samples. Banned at all times.

PeptideWADA CategoryIn/Out of CompetitionYear Added
BPC-157S0 (Non-Approved Substances)BothCovered since S0 inception
TB-500 (Thymosin Beta-4)S2 (Growth Factors)BothNamed compound
CJC-1295S2.2.4 (GH Releasing Factors)BothNamed compound
IpamorelinS2 (GH Secretagogues)BothNamed compound
GHK-CuS0 (Non-Approved, catch-all)BothCovered under S0
KPVS0 (Non-Approved, catch-all)BothCovered under S0
MOTS-cS0 (Non-Approved, catch-all)BothCovered under S0

What S0 Means for Athletes

Strict Liability: The Athlete Is Responsible

Anti-doping rules operate under strict liability. The athlete is responsible for any prohibited substance found in their body, regardless of how it got there. Intent does not matter. The World Anti-Doping Code defines strict liability in Article 2.1. We emphasize this because some athletes mistakenly believe research peptides fall outside anti-doping jurisdiction. They do not.

No Threshold: Any Detectable Amount

Unlike caffeine, S0 substances carry no minimum concentration. Any detectable amount triggers a violation. Mass spectrometry techniques can identify peptide fragments at nanogram-per-milliliter concentrations. There is no "safe" amount for a tested athlete.

Testing Methods for Peptide Detection

WADA-accredited laboratories use liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) to detect peptides. Detection windows vary by peptide, route and metabolism. BPC-157's low molecular weight (1419.5 g/mol) places it within standard LC-MS/MS screening panels.

Peptides Not Explicitly Listed but Still Prohibited

GHK-Cu, KPV, MOTS-c and the S0 Catch-All

Several research peptides are not named but are still prohibited. GHK-Cu, KPV and MOTS-c all lack regulatory approval, placing them under S0 automatically. We have seen forum posts claiming these peptides are "WADA-safe" because they are not named. That claim is wrong. We checked the regulatory status of each one: none has approval from the FDA, EMA, or any other agency. The S0 provision exists to cover unapproved compounds without listing each one individually.

Key Takeaway for Tested Athletes

If you compete under WADA, USADA or any national anti-doping organization, every research peptide discussed on this site is prohibited. No exceptions, no thresholds, no TUE pathways for non-approved substances. The WADA Prohibited List and the USADA substance lookup tool are the authoritative references.

FAQ

Is BPC-157 banned by WADA?

Yes. Prohibited at all times under S0. Any detectable amount constitutes a violation.

Can I get a TUE for BPC-157?

No. Therapeutic use exemptions require an approved indication. BPC-157 has none.

Are topical peptides like GHK-Cu also banned?

Yes. GHK-Cu lacks regulatory approval and is prohibited under S0. Route of administration does not matter.

What happens if I test positive for a research peptide?

A positive test results in an anti-doping rule violation. Sanctions typically include a two-to-four-year suspension for a first offense.

Compare the current picks

Prices, sizes and ratings side by side, updated when the merchant pages change.

Compare peptides